Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - solifenacin succinate, quantity: 5 mg - tablet, orally disintegrating - excipient ingredients: sucralose; hypromellose; lactose monohydrate; polacrilin potassium; croscarmellose sodium; mannitol; sodium stearylfumarate; flavour - vesican odt is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - solifenacin succinate, quantity: 10 mg - tablet, orally disintegrating - excipient ingredients: lactose monohydrate; hypromellose; sucralose; croscarmellose sodium; mannitol; polacrilin potassium; sodium stearylfumarate; flavour - vesican odt is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Australia - English - Department of Health (Therapeutic Goods Administration)

astellas pharma australia pty ltd - solifenacin succinate, quantity: 10 mg - tablet, film coated - excipient ingredients: hypromellose; lactose monohydrate; maize starch; magnesium stearate; titanium dioxide; macrogol 8000; purified talc; iron oxide red - vesicare is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Australia - English - Department of Health (Therapeutic Goods Administration)

astellas pharma australia pty ltd - solifenacin succinate, quantity: 5 mg - tablet, film coated - excipient ingredients: magnesium stearate; hypromellose; lactose monohydrate; maize starch; titanium dioxide; purified talc; iron oxide yellow; macrogol 400 - vesicare is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance pharmaceuticals ltd - sodium chloride - intravesical solution - 9mg/1ml

New Zealand - English - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - solifenacin succinate 10mg;   - film coated tablet - 10 mg - active: solifenacin succinate 10mg   excipient: hypromellose lactose monohydrate magnesium stearate maize starch opadry pink 03f14895 - vesicare is indicated for the treatment of unstable bladder with symptoms of increased urinary urgency, frequent micturition, and/or urge incontinence.

New Zealand - English - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - solifenacin succinate 5mg;   - film coated tablet - 5 mg - active: solifenacin succinate 5mg   excipient: hypromellose lactose monohydrate magnesium stearate maize starch opadry yellow 03f12967 - vesicare is indicated for the treatment of unstable bladder with symptoms of increased urinary urgency, frequent micturition, and/or urge incontinence.

United States - English - NLM (National Library of Medicine)

washington homeopathic products - vesicaria - to relieve the symptoms of head congestion. indications: vesicaria   head congestion if symptoms persist/worsen or if pregnant/nursing, stop use and consult your practitioner.

United States - English - NLM (National Library of Medicine)

washington homeopathic products - vesicaria - to relieve the symptoms of nervousness. indications: vesicaria nervousness if symptoms persist/worsen or if pregnant/nursing, consult your practitioner.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

photocure asa - hexaminolevulinate hydrochloride - powder and solvent for intravesical solution - 85mg